These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 4117192

  • 1. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.
    Evans R, Grant CK, Cox H, Steele K, Alexander P.
    J Exp Med; 1972 Nov 01; 136(5):1318-22. PubMed ID: 4117192
    [Abstract] [Full Text] [Related]

  • 2. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW, De Weger RA, Vandebriel RJ, Den Otter W.
    Immunobiology; 1989 Jun 01; 179(2-3):131-44. PubMed ID: 2676851
    [Abstract] [Full Text] [Related]

  • 3. Thymocytes from mice immunized against an allograft render bone-marrow cells specifically cytotoxic.
    Grant CK, Currie GA, Alexander P.
    J Exp Med; 1972 Jan 01; 135(1):150-64. PubMed ID: 5009704
    [Abstract] [Full Text] [Related]

  • 4. Impairment of allograft tumor immunity by isotype-like suppression of antigen-specific T cell factors.
    Van Loveren H, De Weger RA, Garssen J, Los G, Askenase PW.
    Transplantation; 1989 Mar 01; 47(3):504-12. PubMed ID: 2466354
    [Abstract] [Full Text] [Related]

  • 5. Immunologically specific activation of macrophages armed with the specific macrophage arming factor (SMAF).
    Evans R, Cox H, Alexander P.
    Proc Soc Exp Biol Med; 1973 May 01; 143(1):256-9. PubMed ID: 4703440
    [No Abstract] [Full Text] [Related]

  • 6. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R, Basten A, Nelson DS.
    Int J Cancer; 1975 Mar 15; 15(3):438-50. PubMed ID: 1079792
    [Abstract] [Full Text] [Related]

  • 7. Initial immunochemical characterization of specific macrophage-arming factor.
    De Weger RA, Vandebriel RJ, Slager H, Mans D, Van Loveren H, Wilbrink B, Dullens HF, Den Otter W.
    Cancer Immunol Immunother; 1989 Mar 15; 30(1):21-7. PubMed ID: 2598172
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of immunologically specific cytotoxic macrophages into two types on the basis of radiosensitivity.
    Den Otter W, Evans R, Alexander P.
    Transplantation; 1974 Nov 15; 18(5):421-8. PubMed ID: 4547875
    [No Abstract] [Full Text] [Related]

  • 9. Nonspecific cytotoxicity of spleen cells and the specific cytotoxic action of thymus-derived lymphocytes in vitro.
    Grant CK, Alexander P.
    Cell Immunol; 1974 Oct 15; 14(1):46-51. PubMed ID: 4549557
    [No Abstract] [Full Text] [Related]

  • 10. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
    Horowitz M, Argyris BF.
    Immunol Commun; 1977 Oct 15; 6(3):297-319. PubMed ID: 69610
    [Abstract] [Full Text] [Related]

  • 11. Multiple effector roles of lymphocytes in allograft immunity.
    Grant CK, Evans R, Alexander P.
    Cell Immunol; 1973 Jul 15; 8(1):136-46. PubMed ID: 4542361
    [No Abstract] [Full Text] [Related]

  • 12. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A, Dy M, Thomson N, Hamburger J.
    J Immunol; 1975 Jan 15; 114(1 Pt 1):195-9. PubMed ID: 122985
    [Abstract] [Full Text] [Related]

  • 13. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B, Jones TC.
    Immunology; 1978 Feb 15; 34(2):247-55. PubMed ID: 414994
    [Abstract] [Full Text] [Related]

  • 14. Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts.
    Tigelaar RE, Gorczynski RM.
    J Exp Med; 1974 Jul 01; 140(1):267-89. PubMed ID: 4545897
    [Abstract] [Full Text] [Related]

  • 15. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A, Evans R, Alexander P.
    Br J Cancer; 1977 Jul 01; 36(1):35-40. PubMed ID: 889683
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
    Pels E, den Otter W.
    Cancer Res; 1974 Nov 01; 34(11):3089-94. PubMed ID: 4423930
    [No Abstract] [Full Text] [Related]

  • 18. Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.
    Dullens HF, De Weger RA, Van der Maas M, Den Besten PJ, Vandebriel RJ, Den Otter W.
    Cancer Immunol Immunother; 1989 Nov 01; 30(1):28-33. PubMed ID: 2598173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R, Grant CK.
    Immunology; 1972 Nov 01; 23(5):677-87. PubMed ID: 4673868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.